Revance Therapeutics | 营业利润

Operating Profit 更改 日
AbbVie USD 3.2B 914M 2023-12
ALKERMES USD 43.85M 195.34M 2023-09
Eli Lilly USD 2.39B 1.94B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pacira USD 33.17M 15.45M 2023-12
Supernus Pharmaceuticals USD -996000 9.13M 2023-12



Revance Therapeutics 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2024.